Quest Diagnostics Incorporated (NYSE: DGX), a leader in diagnostic information services, announced that Sam Samad, Executive ...

The Rising Wave of Esoteric Testing The Esoteric Testing Market represents a specialized segment of diagnostic laboratory services that focuses on rare and complex tests not routinely performed in ...

Quest Diagnostics has seen its Fair Value Estimate rise moderately from $191.56 to $197.25 per share, reflecting a more optimistic outlook among analysts. This upward revision is largely due to strong ...

Guardant Health, Inc. shows strong adoption and revenue growth in oncology and data. Click for my updated look at GH stock ...

The Dublin-based firm is developing an array of artificial intelligence-derived tools to improve the efficiency of its digital pathology outsourcing service.

Medicare Part B data show that of the 20 CPT codes seeing the largest increase in payments from 2022 to 2024, all are for molecular- or sequencing-based tests.

The "Sepsis Diagnostics Market 2025-2029 - Global Market Forecasts by Assay, Cause, Product, Lab and Place, with Executive and Consultant Guides" has been added to ResearchAndMarkets.com's offering.

Labcorp on Tuesday raised its annual profit forecast and beat estimates in the third quarter as the laboratory operator ...